Tapewire

Nasdaq · USD

MDWD

MediWound Ltd.

Export transactions ↓
Tapewire entity
296
SEC CIK
0001593984
Parsed reports
16

Last 12 months

Inside the activity.

7 purchase rows · 4 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202610
Jun 202650
Jul 202600
Aug 202603
Sep 202611
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 01, 2026 Filed Sep 2, 2026 20:02 UTC PurchaseOrdinary Shares 525 $12.62 $6,625.50
Disclosure

SEC source: 0001178913-26-004392 · ownership.xml · nonDerivative · entry 4

Rubinstein Samuel · CIK 0001742152 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By spouse

Disclosed balance after: 525

Read SEC document
September 01, 2026 Filed Sep 2, 2026 20:02 UTC SaleOrdinary Shares 525 $12.72 $6,678.00
Disclosure

SEC source: 0001178913-26-004392 · ownership.xml · nonDerivative · entry 3

Rubinstein Samuel · CIK 0001742152 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By spouse

Disclosed balance after: 0

Read SEC document
August 27, 2026 Filed Aug 28, 2026 16:02 UTC
Hess ShmuelCOO & Chief Commercial Officer
Exercise / conversionStock Option (right to buy ordinary shares) · Derivative 11,000 $0.00 Strike: $8.13 $0.00
Disclosure

SEC source: 0001178913-26-004299 · ownership.xml · derivative · entry 8

Hess Shmuel · CIK 0002085305 · COO & Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,000

Underlying: Ordinary Shares · 11,000 shares

Expires 2033-12-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · security: The options reported in this row are the remaining outstanding options from a grant of 39,000 options that were granted to the Reporting Person on December 1, 2023 and that have been vesting in accordance with the following schedule: 25% of the options vested upon the one-year anniversary of the grant date, and an additional 6.25% of the options vest equally on a quarterly basis over the following three years such that they will be fully vested on the four-year anniversary of the grant date.

F9 · security: The Reporting Person exercised 11,000 stock options on a net (cashless) basis. Shares otherwise issuable upon exercise were withheld to satisfy the aggregate exercise price, resulting in the net issuance of 3,958 ordinary shares to the Reporting Person. All 3,958 ordinary shares received upon the net exercise were sold on the same day as reported in Table I.

F4 · derivative.exercise_date: The options reported in this row are the remaining outstanding options from a grant of 39,000 options that were granted to the Reporting Person on December 1, 2023 and that have been vesting in accordance with the following schedule: 25% of the options vested upon the one-year anniversary of the grant date, and an additional 6.25% of the options vest equally on a quarterly basis over the following three years such that they will be fully vested on the four-year anniversary of the grant date.

Read SEC document
August 27, 2026 Filed Aug 28, 2026 16:02 UTC
Hess ShmuelCOO & Chief Commercial Officer
SaleOrdinary Shares 1,979 $13.13 $25,976.35
Disclosure

SEC source: 0001178913-26-004299 · ownership.xml · nonDerivative · entry 3

Hess Shmuel · CIK 0002085305 · COO & Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F9 · security: The Reporting Person exercised 11,000 stock options on a net (cashless) basis. Shares otherwise issuable upon exercise were withheld to satisfy the aggregate exercise price, resulting in the net issuance of 3,958 ordinary shares to the Reporting Person. All 3,958 ordinary shares received upon the net exercise were sold on the same day as reported in Table I.

Read SEC document
August 27, 2026 Filed Aug 28, 2026 16:02 UTC
Hess ShmuelCOO & Chief Commercial Officer
SaleOrdinary Shares 1,979 $12.72 $25,172.88
Disclosure

SEC source: 0001178913-26-004299 · ownership.xml · nonDerivative · entry 2

Hess Shmuel · CIK 0002085305 · COO & Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F9 · security: The Reporting Person exercised 11,000 stock options on a net (cashless) basis. Shares otherwise issuable upon exercise were withheld to satisfy the aggregate exercise price, resulting in the net issuance of 3,958 ordinary shares to the Reporting Person. All 3,958 ordinary shares received upon the net exercise were sold on the same day as reported in Table I.

Read SEC document
August 26, 2026 Filed Aug 28, 2026 16:02 UTC
Hess ShmuelCOO & Chief Commercial Officer
Exercise / conversionStock Option (right to buy ordinary shares) · Derivative 5,000 $0.00 Strike: $8.13 $0.00
Disclosure

SEC source: 0001178913-26-004299 · ownership.xml · derivative · entry 7

Hess Shmuel · CIK 0002085305 · COO & Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,000

Underlying: Ordinary Shares · 5,000 shares

Expires 2033-12-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · security: The options reported in this row are the remaining outstanding options from a grant of 39,000 options that were granted to the Reporting Person on December 1, 2023 and that have been vesting in accordance with the following schedule: 25% of the options vested upon the one-year anniversary of the grant date, and an additional 6.25% of the options vest equally on a quarterly basis over the following three years such that they will be fully vested on the four-year anniversary of the grant date.

F8 · security: The Reporting Person exercised 5,000 stock options on a net (cashless) basis. Shares otherwise issuable upon exercise were withheld to satisfy the aggregate exercise price, resulting in the net issuance of 1,865 ordinary shares to the Reporting Person. All 1,865 ordinary shares received upon the net exercise were sold on the same day as reported in Table I.

F4 · derivative.exercise_date: The options reported in this row are the remaining outstanding options from a grant of 39,000 options that were granted to the Reporting Person on December 1, 2023 and that have been vesting in accordance with the following schedule: 25% of the options vested upon the one-year anniversary of the grant date, and an additional 6.25% of the options vest equally on a quarterly basis over the following three years such that they will be fully vested on the four-year anniversary of the grant date.

Read SEC document
August 26, 2026 Filed Aug 28, 2026 16:02 UTC
Hess ShmuelCOO & Chief Commercial Officer
SaleOrdinary Shares 1,865 $13.00 $24,245.00
Disclosure

SEC source: 0001178913-26-004299 · ownership.xml · nonDerivative · entry 1

Hess Shmuel · CIK 0002085305 · COO & Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F8 · security: The Reporting Person exercised 5,000 stock options on a net (cashless) basis. Shares otherwise issuable upon exercise were withheld to satisfy the aggregate exercise price, resulting in the net issuance of 1,865 ordinary shares to the Reporting Person. All 1,865 ordinary shares received upon the net exercise were sold on the same day as reported in Table I.

Read SEC document
June 03, 2026 Filed Jun 4, 2026 20:05 UTC PurchaseOrdinary Shares 5,825 $14.00 $81,550.00
Disclosure

SEC source: 0001178913-26-003106 · zk2635499.xml · nonDerivative · entry 2

SHAMIR NACHUM · CIK 0001622164 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,815

Read SEC document
June 03, 2026 Filed Jun 4, 2026 20:05 UTC PurchaseOrdinary Shares 175 $13.98 $2,445.63
Disclosure

SEC source: 0001178913-26-003106 · zk2635499.xml · nonDerivative · entry 1

SHAMIR NACHUM · CIK 0001622164 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,990

Read SEC document
June 01, 2026 Filed Jun 2, 2026 11:30 UTC PurchaseOrdinary Shares 1,797 $14.00 $25,149.02
Disclosure

SEC source: 0001178913-26-003036 · zk2635475.xml · nonDerivative · entry 3

Fox David Morton · CIK 0001829578 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,283

Read SEC document
June 01, 2026 Filed Jun 2, 2026 11:30 UTC PurchaseOrdinary Shares 10 $14.23 $142.30
Disclosure

SEC source: 0001178913-26-003036 · zk2635475.xml · nonDerivative · entry 2

Fox David Morton · CIK 0001829578 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,486

Read SEC document
June 01, 2026 Filed Jun 2, 2026 11:30 UTC PurchaseOrdinary Shares 1,730 $14.23 $24,609.25
Disclosure

SEC source: 0001178913-26-003036 · zk2635475.xml · nonDerivative · entry 1

Fox David Morton · CIK 0001829578 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,476

Read SEC document
May 29, 2026 Filed Jun 1, 2026 11:00 UTC PurchaseOrdinary Shares 150 $14.33 $2,149.50
Disclosure

SEC source: 0001178913-26-003002 · ownership.xml · nonDerivative · entry 1

Rubinstein Samuel · CIK 0001742152 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,993

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.